This inventor holds 7 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: The University of New Mexico, Loyola University of Chicago. Active years: 2014-2025.
Location History:
- Albuquerque, NM (US) (2014 - 2020)
- Jacksonville Beach, FL (US) (2022)
Company Filing History:
7 out of 942 
2 out of 74 
Years Active: 2014-2025
Title: The Innovative Contributions of Ravi Durvasula
Introduction
Ravi Durvasula is a prominent inventor based in Albuquerque, NM (US). He has made significant contributions to the field of biomedical research, particularly in the development of compositions that target pain and filovirus infections. With a total of 7 patents to his name, Durvasula's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of his latest patents is focused on compositions comprising antibodies or antibody fragments that bind to the P2X4 receptor. This innovative composition is designed for treating pain and includes an antibody or antibody fragment that specifically targets a receptor involved in pain. The composition may be used to treat both acute and chronic pain in subjects. Additionally, it can reverse pain-related mechanical, cold, anxiety-like, and depression-like behaviors in neuropathic pain and chemotoxic nerve injury models. Another notable patent involves filovirus antibodies and methods. This patent describes an antibody that binds to a filovirus glycoprotein, which can be used to detect filovirus in biological samples. The antibody can also be formulated into a pharmaceutical composition for administering to subjects at risk of filovirus infection.
Career Highlights
Ravi Durvasula has worked at esteemed institutions such as the University of New Mexico and Loyola University of Chicago. His research has focused on developing innovative solutions to complex medical challenges, particularly in the realm of pain management and infectious diseases.
Collaborations
Throughout his career, Durvasula has collaborated with notable colleagues, including Adinarayana Kunamneni and Karin Westlund High. These collaborations have further enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Ravi Durvasula's contributions to the field of biomedical research are noteworthy, particularly in the development of novel compositions for pain relief and filovirus detection. His work exemplifies the impact of innovation in addressing critical health issues.